Casa Grande
Revenue Projection
Adjust the levers
Every figure below recalculates live. Defaults reflect current operating reality: 600 billable tests/week, Banner dropped (necessary toxicology only), 3 PGx/day, and the actual TLCR payer mix.
| Line | Billed | Collected |
|---|
Actual payer mix
Pulled from the live week-to-date requisition report (382 test-components, 5/18–5/22). This is the mix Casa Grande is modeled on. Banner reimburses $0 through the Genics/Recon arrangement (Sonora Quest only), which is why dropping it lifts the blended rate.
| Payer category | Tests | Billed | Collected | Rate |
|---|---|---|---|---|
| AZ Complete + ONN-AZ Complete | 232 | $52,027 | $36,419 | 70% |
| Other — AHCCCS / Molina / UHC / Medicare Adv | 87 | $23,062 | $15,452 | 67% |
| Banner / Mercy — Sonora Quest only | 45 | $11,405 | $0 | $0 |
| WellCare by Allwell | 8 | $2,189 | $1,751 | 80% |
| INS unlisted — pending cleanup | 10 | $1,293 | $0 | pend |
| Total — as actually run | 382 | $89,976 | $53,622 | 59.6% |
Model assumptions
- Payroll: current site (2 @ $16, 1 @ $20, 32 hrs = $1,664/wk) + Casa Grande (3 @ $16, 32 hrs = $1,536/wk) = $13,760/mo
- Per-test economics from collecting-payer mix: $236 billed / $164 collected avg
- PGx (81418) list $917.08, collected @ 67% (Medicare-side)
- Banner dropped → blended rate rises 59.6% → 69.4%
- 5 clinic days/week · 4.3 weeks/month
- PGx requires ≥6 genes incl. CYP2C19 + CYP2D6 + dup/del to bill
Path to $50K Net
The Plan in Brief
PGx — The High-Value Add
New Expense Structure
| Item | Monthly |
|---|---|
| Current base (Ted + field payroll) | $14,635 |
| + Second provider | $2,000 |
| + 3 employees @ 32 hrs/wk @ $16 | $6,656 |
| New Monthly Expense Base | $23,291 |
Projection — 2 Providers + PGx @ 15%
| Daily Volume | Schedule | Total Rev | Net Profit |
|---|---|---|---|
| 50 pts + 3 PGx | 5 day | $64,142 | +$40,851 |
| 60 pts + 3 PGx | 5 day | $75,754 | +$52,463 |
| 60 pts + 3 PGx | 6 day | $89,528 | +$66,237 |
| 70 pts + 3 PGx | 6 day | $103,251 | +$79,960 |
The Target Number
6-day week: ~48 regular patients/day + 3 PGx
With two providers, 60 patients/day is ~30 each — the same clean-day pace one provider already hits. The second provider is the unlock that one-provider scaling could not reach (capped ~$43K).
2. PGx must meet medical necessity. CPT 81418 requires ≥6 genes (incl. CYP2C19 + CYP2D6) and an active medication indication. Clean PGx orders hold this revenue; denials soften it. PGx revenue here is estimated at a 67% approval rate.
Lab billing & collection by Genics Lab / Recon Diagnostics · Figures depend on actual remittance
May 2026
Performance & Projection
Where May stands today
From the requisition report (1,321 final/pending accessions; 68 rejected excluded) plus 20 PGx run this month through the separate genetics stream. PGx is not in the requisition report — it's added here at $917.08 list, 67% collected.
Tracking to month-end vs $50K goal
Straight-line projection at the current pace (19 of 31 days → ×1.63). The white line on each meter marks the $50,000 net target.
Who paid — and who didn't
AZ Complete is the engine — 709 components, 68% of all collections. But Banner is the story: 509 components billing $101K and collecting nothing. Strip Banner and the blended rate jumps from 42% to 59.6%.
| Payer category | Tests | Billed | Collected | Rate |
|---|---|---|---|---|
| AZ Complete + ONN-AZ Complete | 709 | $141,476 | $99,033 | 70% |
| Banner / Mercy — Sonora Quest only | 509 | $101,240 | $0 | $0 |
| Medicaid / Other (AHCCCS·Molina·UHC) | 237 | $45,772 | $30,667 | 67% |
| INS pending — cleanup | 171 | $34,483 | $0 | pend |
| Medicare Advantage | 61 | $17,402 | $11,659 | 67% |
| WellCare | 20 | $5,379 | $4,303 | 80% |
| Panels total | 1,707 | $345,753 | $145,663 | 42.1% |
March → April → May
| Period | Collected | Blended rate | Net to Linea (diff.) |
|---|---|---|---|
| March | $14,556 | 43% | ~$2,200 |
| April | $40,202 | 58% | ~$6,200 |
| May (proj. full month) | $257,711 | — | $37,363 |
May's projected collections are ~6× April's — the volume curve is steep and accelerating.
The path to $50K
May is tracking to 75% of goal on the differentiated split — the closest yet, and the gap (~$12.6K) is explained almost entirely by three fixable levers, all already in motion:
Reaching 75% of target while a third of volume earns nothing and PGx is barely running is the strongest signal yet that the model works once Casa Grande comes online with Banner dropped and PGx flowing.
March & April
The Slow Start
Where the launch landed
March and April are combined here because volume was still ramping — these were the build-out months as the AZ operation came online. The numbers are real (final + pending accessions; 13 rejected excluded).
March → April momentum
April nearly tripled March's collections — the operation was finding its footing. This is the trajectory that May continues.
Who paid
Early mix skewed toward Medicaid/Other and Medicare Advantage — AZ Complete volume hadn't yet become the engine it is in May. INS-pending and Banner together left ~$21K billed uncollected.
| Payer category | Tests | Billed | Collected | Rate |
|---|---|---|---|---|
| Medicaid / Other (AHCCCS·Molina·UHC) | 206 | $47,855 | $32,063 | 67% |
| Medicare Advantage | 96 | $26,429 | $17,707 | 67% |
| INS pending — cleanup | 87 | $11,919 | $0 | pend |
| Banner / Mercy — Sonora Quest only | 43 | $9,632 | $0 | $0 |
| AZ Complete | 22 | $4,513 | $3,159 | 70% |
| WellCare | 9 | $2,286 | $1,829 | 80% |
| Total | 463 | $102,633 | $54,758 | 53.4% |
Read on the launch period
March and April were never going to hit the $50K target — they were the ramp. Combined net to Linea was ~$8.2K (15%) to ~$10.9K (differentiated) across two months, which is below the monthly payroll line on its own. That's expected for a launch.
What matters is the trajectory: April collected 2.8× March, and the AZ Complete volume that now drives May was only just beginning (22 components here vs 709 in May MTD). No PGx ran in this period either — the highest-value product hadn't started.
This is the baseline the Casa Grande pilot builds from — not a target, but proof the model scales once volume, payer mix, and PGx come online.
Peptide Sales Report
Log each peptide sale. Profit splits calculate automatically.